Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis

Journal of Neuroimmunology

Volumn 223, Issue 1-2, 2010, Pages 92-99

  O'Connor, K C ^a   Lopez Amaya, C ^b   Gagne, D ^c   Lovato, L ^a   Moore Odom, N H ^a   Kennedy, J ^b   Krupp, L ^d   Tenembaum, S ^e   Ness, J ^f   Belman, A ^d   Boyko, A ^g   Bykova, O ^g   Mah, J K ^h   Stoian, C A ^h   Waubant, E ⁱ   Kremenchutzky, M ^j   Ruggieri, M ^k   Bardini, M R ^l   Rensel, M ^m   Hahn, J ⁿ   Weinstock Guttman, B ^o   Yeh, E A ^o   Farrell, K ^p   Freedman, M S ^q   Iivanainen, M ^r   Bhan, V ^s   Dilenge, M ^t   Hancock, M A ^u   Gano, D ^c   Fattahie, R ^c   Kopel, L ^c   Fournier, A E ^c   Moscarello, M ^b   Banwell, B ^v   Bar Or, A ^c   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d STONY BROOK UNIVERSITY   (United States)

^e HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^h UNIVERSITY OF CALGARY   (Canada)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j London Health Sciences ^*  (Canada)

^k UNIVERSITY OF CATANIA   (Italy)

^l UNIVERSITY OF FLORENCE   (Italy)

^m LERNER RESEARCH INSTITUTE   (United States)

ⁿ STANFORD UNIVERSITY   (United States)

^o UNIVERSITY AT BUFFALO   (United States)

^p UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^q UNIVERSITY OF OTTAWA   (Canada)

^r UNIVERSITY OF HELSINKI   (Finland)

^s DALHOUSIE UNIVERSITY   (Canada)

^t MONTREAL CHILDREN S HOSPITAL   (Canada)

^u MCGILL UNIVERSITY   (Canada)

^v HOSPITAL FOR SICK CHILDREN   (Canada)

more..

Author keywords

Autoantibodies; Autoimmunity; Multiple sclerosis; Myelin basic protein; Pediatric disease (CNS)

Indexed keywords

MYELIN; MYELIN BASIC PROTEIN;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EQUILIBRIUM CONSTANT; HUMAN; IMMUNOBLOTTING; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MULTIPLE SCLEROSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RISK FACTOR; SURFACE PLASMON RESONANCE;

ACUTE DISEASE; ADOLESCENT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE TISSUE PROTEINS; RISK FACTORS; SYNDROME; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 77953540771     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.02.019     Document Type: Article

References (35)

1. Banwell B., Ghezzi A., Bar-Or A., Mikaeloff Y., Tardieu M. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet. Neurol. 2007, 6:887-902.
2. Banwell B., Krupp L., Kennedy J., Tellier R., Tenembaum S., Ness J., Belman A., Boiko A., Bykova O., Waubant E., Mah J.K., Stoian C., Kremenchutzky M., Bardini M.R., Ruggieri M., Rensel M., Hahn J., Weinstock-Guttman B., Yeh E.A., Farrell K., Freedman M., Iivanainen M., Sevon M., Bhan V., Dilenge M.E., Stephens D., Bar-Or A. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet. Neurol. 2007, 6:773-781.
3. Bar-Or A. The immunology of multiple sclerosis. Semin. Neurol. 2008, 28:29-45.
4. Bar-Or A., Calabresi P.A., Arnold D., Markowitz C., Shafer S., Kasper L.H., Waubant E., Gazda S., Fox R.J., Panzara M., Sarkar N., Agarwal S., Smith C.H. Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. Ann. Neurol. 2008, 63:395-400.
5. Brilot F., Dale R.C., Selter R.C., Grummel V., Kalluri S.R., Aslam M., Busch V., Zhou D., Cepok S., Hemmer B. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann. Neurol. 2009, 66:833-842.
6. Butcher H., Kennette W., Collins O., Demoor J., Koropatnick J. A sensitive time-resolved fluorescent immunoassay for metallothionein protein. J. Immunol. Methods 2003, 272:247-256.
7. Cheifetz S., Moscarello M.A. Effect of bovine basic protein charge microheterogeneity on protein-induced aggregation of unilamellar vesicles containing a mixture of acidic and neutral phospholipids. Biochemistry 1985, 24:1909-1914.
8. Chou F.C., Chou C.H., Shapira R., Kibler R.F. Basis of microheterogeneity of myelin basic protein. J. Biol. Chem. 1976, 251:2671-2679.
9. Elkon K., Casali P. Nature and functions of autoantibodies. Nat. Clin. Pract. Rheumatol. 2008, 4:491-498.
10. Giacomini P.S., Darlington P.J., Bar-Or A. Emerging multiple sclerosis disease-modifying therapies. Curr. Opin. Neurol. 2009, 22:226-232.
11. Hauser S.L., Waubant E., Arnold D.L., Vollmer T., Antel J., Fox R.J., Bar-Or A., Panzara M., Sarkar N., Agarwal S., Langer-Gould A., Smith C.H. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 2008, 358:676-688.
12. Kidd B.A., Ho P.P., Sharpe O., Zhao X., Tomooka B.H., Kanter J.L., Steinman L., Robinson W.H. Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis Res. Ther. 2008, 10:R119.
13. Kim J.K., Mastronardi F.G., Wood D.D., Lubman D.M., Zand R., Moscarello M.A. Multiple sclerosis: an important role for post-translational modifications of myelin basic protein in pathogenesis. Mol. Cell. Proteomics 2003, 2:453-462.
14. Klareskog L., Ronnelid J., Lundberg K., Padyukov L., Alfredsson L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu. Rev. Immunol. 2008, 26:651-675.
15. Krupp L.B., Banwell B., Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007, 68:S7-S12.
16. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452.
17. Lassmann H., Brunner C., Bradl M., Linington C. Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol. 1988, 75:566-576.
18. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 2000, 47:707-717.
19. Mastronardi F.G., Moscarello M.A. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis. J. Neurosci. Res. 2005, 80:301-308.
20. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 2001, 50:121-127.
21. McLaughlin K.A., Chitnis T., Newcombe J., Franz B., Kennedy J., McArdel S., Kuhle J., Kappos L., Rostasy K., Pohl D., Gagne D., Ness J.M., Tenembaum S., O'Connor K.C., Viglietta V., Wong S.J., Tavakoli N.P., de Seze J., Idrissova Z., Khoury S.J., Bar-Or A., Hafler D.A., Banwell B., Wucherpfennig K.W. Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J. Immunol. 2009, 183:4067-4076.
22. Myszka D.G. Improving biosensor analysis. J. Mol. Recognit. 1999, 12:279-284.
23. O'Connor K.C., Appel H., Bregoli L., Call M.E., Catz I., Chan J.A., Moore N.H., Warren K.G., Wong S.J., Hafler D.A., Wucherpfennig K.W. Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J. Immunol. 2005, 175:1974-1982.
24. O'Connor K.C., Chitnis T., Griffin D.E., Piyasirisilp S., Bar-Or A., Khoury S., Wucherpfennig K.W., Hafler D.A. Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions. J Neuroimmunol 2003, 136:140-148.
25. Pol E., Karlsson R., Roos H., Jansson A., Xu B., Larsson A., Jarhede T., Franklin G., Fuentes A., Persson S. Biosensor-based characterization of serum antibodies during development of an anti-IgE immunotherapeutic against allergy and asthma. J Mol Recognit 2007, 20:22-31.
26. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 1983, 13:227-231.
27. Prat A., Antel J. Pathogenesis of multiple sclerosis. Curr. Opin. Neurol. 2005, 18:225-230.
28. Reindl M., Linington C., Brehm U., Egg R., Dilitz E., Deisenhammer F., Poewe W., Berger T. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain 1999, 122:2047-2056.
29. Schluesener H.J., Sobel R.A., Linington C., Weiner H.L. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 1987, 139:4016-4021.
30. van Venrooij W.J., Pruijn G.J. Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res. 2000, 2:249-251.
31. Vojdani A., Vojdani E., Cooper E. Antibodies to myelin basic protein, myelin oligodendrocytes peptides, alpha-beta-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis. J. Intern. Med. 2003, 254:363-374.
32. Whitaker J.N., Kirk K.A., Herman P.K., Zhou S.R., Goodin R.R., Moscarello M.A., Wood D.D. An immunochemical comparison of human myelin basic protein and its modified, citrullinated form, C8. J. Neuroimmunol. 1992, 36:135-146.
33. Wood D.D., Bilbao J.M., O'Connors P., Moscarello M.A. Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann. Neurol. 1996, 40:18-24.
34. Wood D.D., Moscarello M.A. The isolation, characterization, and lipid-aggregating properties of a citrulline containing myelin basic protein. J. Biol. Chem. 1989, 264:5121-5127.
35. Wrammert J., Smith K., Miller J., Langley W.A., Kokko K., Larsen C., Zheng N.Y., Mays I., Garman L., Helms C., James J., Air G.M., Capra J.D., Ahmed R., Wilson P.C. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008, 453:667-671.